Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
July 16, 2019
MediWound to Host Analyst Day on its Innovative Product EscharEx® for Debridement of Chronic Wounds
YAVNE, Israel, July 16, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
July 16, 2019
Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina
VANCOUVER, July 16, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve ...
July 16, 2019
Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan
Saint Herblain (France), July 16, 2019 – Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major ...
July 16, 2019
Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-ANG3
PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals Inc. (ARWR) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ARO-ANG3 for ...
July 15, 2019
Isofol Announces Recent Advisory Board Meeting Covering Development Plan for Arfolitixorin
GOTHENBURG, Sweden, July 15, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced the outcome of an advisory board meeting ...
July 15, 2019
Orphazyme appoints Kim Stratton as Chief Executive Officer
Copenhagen, July 15, 2019 – Orphazyme A/S (ORPHA.CO), a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announces that the Company’s ...
July 15, 2019
RedHill Biopharma to Host Second Quarter 2019 Financial Results Conference Call on July 23, 2019
TEL-AVIV, Israel and RALEIGH, N.C., July 15, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a ...
July 15, 2019
Altimmune Announces Closing of Acquisition of Spitfire Pharma, Inc.
GAITHERSBURG, Md., July 15, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced the closing of the previously announced acquisition of ...
July 15, 2019
HTG Expands RUO Profiling Menu with New Platform Compatibility Assays
TUCSON, Ariz., July 15, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today ...
July 15, 2019
Beyond Air™ Announces New NASDAQ Ticker Symbol is XAIR
GARDEN CITY, N.Y. and REHOVOT, Israel, July 15, 2019 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR), a clinical-stage medical device and biopharmaceutical company focused on ...
July 15, 2019
NeuBase Therapeutics Initiates Trading on NASDAQ Under Ticker Symbol “NBSE”
PITTSBURGH, July 15, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” and the “Company”), a biotechnology company developing next generation antisense therapies to ...
July 11, 2019
Spring Bank Pharmaceuticals Announces Election of Pamela Klein, M.D., to its Board of Directors
HOPKINTON, Mass., July 10, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral ...
July 11, 2019
iCAD’s ProFound AI™ for 2D Mammography Receives CE Mark Approval
NASHUA, N.H., July 11, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced ...
July 11, 2019
AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with Down Syndrome
LAUSANNE, Switzerland, July 11, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, ...
July 11, 2019
Actinium Highlights Two Presentations at the Health Physics Society Annual Meeting Supporting the Safety Profile of Iomab-B for SIERRA Trial Caregivers
NEW YORK, July 11, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc.  (NYSE AMERICAN: ATNM) ("Actinium") today highlighted its presence at the Health Physics Society ("HPS") 64th ...
July 10, 2019
ORYZON to Present Data From ETHERAL Phase IIa Trial at the 2019 Alzheimer's Association International Conference in Los Angeles
MADRID, Spain and CAMBRIDGE, Mass., July 10, 2019 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics ...
July 10, 2019
Orchestra BioMed™ Completes $34 Million Financing to Accelerate Product Pipeline Development and Advance Partnerships
NEW HOPE, Pa., July 10, 2019 (GLOBE NEWSWIRE) --  Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for ...
July 10, 2019
aTyr Pharma to Host Key Opinion Leader Call and Webcast on Sarcoidosis and the Current Treatment Landscape
SAN DIEGO, July 10, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based ...
July 10, 2019
SimonMed Imaging Implements the First FDA-Cleared 3D Tomosynthesis Software Using Artificial Intelligence
PHOENIX and NASHUA, N.H., July 10, 2019 (GLOBE NEWSWIRE) -- SimonMed Imaging, one of the largest outpatient medical imaging providers and largest physician radiology practices ...
July 10, 2019
Multiple Abstracts Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) to be Presented at the American Headache Society’s 61st Annual Scientific Meeting
BASKING RIDGE, N.J., July 10, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a global commercial-stage bioelectronic medicine company, today announced data presentations focused on non-invasive ...
Page 17 of 169